Physician

Muhammad Azam Hussain, M.D.

According to 2025 Medicare claims, Muhammad Hussain, M.D. (NPI: 1245564087) practices hematology/oncology in the Albany-Schenectady-Troy, NY market, with the plurality of this provider's patient population coming from Saratoga, NY. This provider's primary affiliated billing organization is NEW YORK ONCOLOGY HEMATOLOGY, P.C. (NPI: 1609863448; TIN: 141799724) and primary practice location at 12065-4172. Hussain is affiliated with the CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Hussain's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 838 traditional Medicare patients, billed 158,421 HCPCS/CPT codes, and received $3,065,137 in Medicare payments. The top billing code was 99213 (Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more). Part D data shows 2,925 prescription claims across 294 beneficiaries totaling $8,796,589 in drug costs, led by Lenalidomide (Lenalidomide). Open Payments data shows 2 records totaling $154. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $25,147 to $3,065,137. Similarly, Part D prescription costs have moved sharply higher in recent years, from $51,585 to $8,796,589. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	68	301	$25,147
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	132	6,593	$173,381
2019	428	39,271	$733,587
2020	511	56,571	$1,236,115
2021	570	71,093	$1,526,561
2022	752	132,463	$2,249,642
2023	808	143,454	$1,987,161
2024	838	158,421	$3,065,137

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	32	150	$51,585
2016	20	38	$1,824
2017	30	69	$7,308
2018	53	193	$305,747
2019	114	670	$1,007,271
2020	170	1,362	$2,454,224
2021	197	1,795	$5,154,425
2022	231	2,032	$5,436,996
2023	240	2,284	$6,267,149
2024	294	2,925	$8,796,589

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	225	267	$59
80053	Blood test, comprehensive group of blood chemicals	514	1,436	$10
36415	Insertion of needle into vein for collection of blood sample	531	1,564	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	541	1,533	$8
83615	Lactate dehydrogenase (enzyme) level	356	933	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Lenalidomide	Lenalidomide	133	3,556	$1,510,943
Pomalyst	Pomalidomide	56	1,568	$1,324,035
Venclexta	Venetoclax	88	2,483	$947,566
Revlimid	Lenalidomide	58	1,644	$870,707
Ninlaro	Ixazomib Citrate	55	1,540	$750,932

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	2	$154	Pharmacosmos Therapeutics Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Muhammad Azam Hussain, M.D.?

Tedicare shows public-source Medicare data for Muhammad Azam Hussain, M.D. (NPI 1245564087), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Muhammad Azam Hussain, M.D. have ACO affiliation data?

Muhammad Azam Hussain, M.D. is shown with ACO affiliation data for CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Muhammad Azam Hussain, M.D.?

Muhammad Azam Hussain, M.D. is linked to NEW YORK ONCOLOGY HEMATOLOGY, P.C. (billing NPI 1609863448) in the available physician profile data.

Does Muhammad Azam Hussain, M.D. have Open Payments data?

Muhammad Azam Hussain, M.D. has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.